Browsing publications by Dr Quentin Anstee

Newcastle AuthorsTitleYearFull text
Dr Quentin Anstee
Elafibranor, an Agonist of the Peroxisome Proliferator−Activated Receptor−α and −δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening2016
Dr Dave Houghton
Dr Kate Hallsworth
Dr Kieren Hollingsworth
Professor Roy Taylor
Professor Chris Day
et al.
Exercise reduces liver fat and improves body composition but not insulin sensitivity or inflammatory markers in non-alcoholic steatohepatitis2016
Dr Timothy Hardy
Dr Mujdat Zeybel
Professor Chris Day
Dr Christian Dipper
Dr Steven Masson
et al.
Plasma DNA methylation: A potential biomarker for stratification of liver fibrosis in non-alcoholic fatty liver disease2016
Dr Quentin Anstee
Review article: emerging anti-fibrotic therapies in the treatment of non-alcoholic steatohepatitis2016
Dr Mujdat Zeybel
Dr Timothy Hardy
Stuart Robinson
Christopher Fox
Dr Quentin Anstee
et al.
Differential DNA methylation of genes involved in fibrosis progression in non-alcoholic fatty liver disease and alcoholic liver disease2015
Anna Whitehead
Dr Gillian Patman
Professor Chris Day
Dr Dina Tiniakos
Dr Quentin Anstee
et al.
Effects of FXR agonist PX20606 on tumour formation in animal models of non-alcoholic fatty liver disease2015
Dr Stuart McPherson
Dr Timothy Hardy
Elsbeth Henderson
Professor Alastair Burt
Professor Chris Day
et al.
Evidence of NAFLD progression from steatosis to fibrosing-steatohepatitis using paired biopsies: Implications for prognosis and clinical management2015
Dr Dave Houghton
Dr Christian Thoma
Dr Kate Hallsworth
Dr Kieren Hollingsworth
Professor Chris Day
et al.
Exercise reduces liver fat, visceral fat and circulating triglycerides, but not circulating inflammatory markers in non-alcoholic steatohepatitis2015
Dr Quentin Anstee
Professor Ann Daly
Professor Chris Day
Genetics of Alcoholic Liver Disease2015
Dr Stuart McPherson
Dr Timothy Hardy
Professor Alastair Burt
Professor Chris Day
Dr Quentin Anstee
et al.
High rate of false positives for advanced fibrosis when simple non-invasive fibrosis tests are used in older patients (>=65 years) with NAFLD2015
123456789101112